Assembly Biosciences, Inc. (ASMB) Total liabilities 2016–2025
Assembly Biosciences, Inc. (ASMB) total liabilities at each fiscal year-end, per SEC filings.
$50.8MFY2025 · since FY2016: $18.2M → $50.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $50.8M | -40.8% |
| FY2024 | $85.8M | -10.4% |
| FY2023 | $95.7M | +400.4% |
| FY2022 | $19.1M | -13.6% |
| FY2021 | $22.1M | -48.1% |
| FY2020 | $42.7M | -36.0% |
| FY2019 | $66.7M | +16.2% |
| FY2018 | $57.4M | +2.2% |
| FY2017 | $56.2M | +208.0% |
| FY2016 | $18.2M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice